Suleyman Demirel University   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Isparta Turkey (1976)

Organization Overview

First Clinical Trial
2006
NCT00308841
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ayşe Aydınlı | Suleyman Demirel University | Suleyman Demirel University Faculty of Dentistry Pediatric Dentistry Department | Suleyman Demirel University Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Coronary Artery Disease (Phase 3)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

ST Elevation Myocardial Infarction (Phase 3)

Stroke (Phase 3)

Thromboembolism (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 12